Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew R. Allen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lynx1 Capital Management LP - $3.50M in CGEM purchases and sales in the last 12 months
- Jennifer Michaelson - $1.62M in CGEM purchases and sales in the last 12 months
- Nadim Ahmed - $518K in CGEM purchases and sales in the last 12 months
- Jeffrey Alan Jones - $179K in CGEM purchases and sales in the last 12 months
- Jacquelyn L. Sumer - $137K in CGEM purchases and sales in the last 12 months
- Mary Kay Fenton - $60K in CGEM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew R. Allen?
Andrew R. Allen is a corporate insider of Cullinan Therapeutics, Inc. (CGEM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Andrew R. Allen last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 2 filings going back to 2025.